z-logo
open-access-imgOpen Access
Protective effects of omega‐3 fatty acids against Alzheimer's disease in rat brain endothelial cells
Author(s) -
Wang Lijun,
Fan Hongguang,
He Jingchun,
Wang Lifang,
Tian Zelong,
Wang Chaoran
Publication year - 2018
Publication title -
brain and behavior
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.915
H-Index - 41
ISSN - 2162-3279
DOI - 10.1002/brb3.1037
Subject(s) - lipid peroxidation , glutathione peroxidase , catalase , superoxide dismutase , biochemistry , glutathione , antioxidant , reactive oxygen species , polyunsaturated fatty acid , biology , docosahexaenoic acid , chemistry , fatty acid , enzyme
Objectives Omega‐3 fatty acids are well‐known unsaturated fatty acids that are essential for growth and development in animals. They primarily participate in the development of intelligence, the nervous system, and vision, and the metabolism of neurotransmitters. Omega‐3 fatty acids have been widely studied in the treatment of Alzheimer's disease ( AD ). Omega‐3 fatty acids are known to have neuroprotective effects due to their antioxidant capacity. Rotenone has been shown to induce neurotoxicity in vitro. Methods We investigated the protective effects of omega‐3 fatty acids against AD in rat brain microvascular endothelial cells ( RBMVEC s) in vitro. Lipid peroxidation, reactive oxygen species ( ROS ), glutathione peroxidase (Gpx), reduced glutathione ( GSH ), superoxide dismutase ( SOD ), and catalase levels were evaluated in RBMVEC s. Flow cytometry was performed to assess apoptosis. Results Lipid peroxidation and ROS were reduced in RBMVEC s following incubation with omega‐3 fatty acids. Catalase, Gpx, and SOD were increased in RBMVEC s following incubation with omega‐3 fatty acids. Flow cytometry showed that incubation with omega‐3 fatty acids reduced the amount of apoptotic RBMVEC s. Conclusion Our results suggest that omega‐3 fatty acids show potential as a therapeutic agent against AD .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here